Lv4
800 积分 2024-01-14 加入
Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities
2天前
已完结
Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors
2天前
已完结
Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC
2天前
已完结
Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity
2天前
已完结
Targeting Gatekeeper Mutations for Kinase Drug Discovery
1个月前
已完结
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors
1个月前
已完结
Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir
3个月前
已完结
Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells
3个月前
已完结
Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity
3个月前
已完结
FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review
3个月前
已完结
皖公网安备34019202002308
